Rivaroxaban Sotorasib Interaction Study
NCT06314763
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Drug Drug Interaction Study
Interventions
DRUG:
Rivaroxaban 20mg
DRUG:
Sotorasib 960mg
Sponsor
Radboud University Medical Center
Collaborators
[object Object]